Search Results 301-310 of 19710 for Receptor
... receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, PIK3CAmutated, advanced or metastatic (cancer that has spread) breast ...
Thyroid Cancer Risk with GLP-1 Receptor Agonists: Evidence, Knowledge Gaps, and the Path Forward. Thyroid. 2025 Jan; 35 (1):3-5 Epub 2025 Jan 08. View PubMed ...
... receptor-T cell therapy featured image. Biotherapeutics. Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy. Marla ...
Research · Medical Innovation · Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy featured image · Research · Expert Alert: ...
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are cornerstone therapies for type 2 diabetes, obesity and cardiovascular health. Their widespread use ...
Medical Innovation · Science Saturday: Addressing the challenges of chimeric antigen receptor-T cell therapy featured image · Research · Expert Alert: What a ...
Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non- · Research · Research · Science Saturday: What you should know about ...
CAPS is a rare, inherited disease of the immune system. Canakinumab injection is also used to treat tumor necrosis factor receptor associated periodic syndrome ...
The antibody linked with Graves' disease is called thyrotropin receptor antibody (TRAb). TRAb takes over the work of the pituitary hormone. That leads to ...
Chimeric antigen receptor (CAR)-T cell therapy is emerging as a promising option for patients with certain types of cancer. The advent of this immunotherapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.